SCHEMBL2565634

SCHEMBL2565634

NS(=O)(=O)c1cccnc1-c1ccncc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 9/20 0.50
CA1 P00915 8/20 0.50
CA9 Q16790 6/20 0.50
MAPK1 P28482 1/20 0.50
LRRK2 Q5S007 2/20 0.44
CA12 O43570 5/20 0.43
CA14 Q9ULX7 4/20 0.43
FTO Q9C0B1 1/20 0.42
LMNA P02545 2/20 0.42
IDO1 P14902 3/20 0.39
TDO2 P48775 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP11B1 P15538 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784140 0.87 CA1 (0.51) CA2CA1CA9MAPK1CA12
Hydrochloric Acid SCHEMBL29970039 0.81 CA2 (0.53) CA2CA1CA9MAPK1CA12
SCHEMBL12474849 0.76 CA1 (0.47) CA2CA1CA9MAPK1LMNA
SCHEMBL28216449 0.76 CA2 (0.47) CA2CA1CA9MAPK1CA12
SCHEMBL29718566 0.76 CA2 (0.47) CA2CA1CA9MAPK1CA12
SCHEMBL8514484 0.75 CA2 (0.50) CA2CA1CA9MAPK1CA12
SCHEMBL6292017 0.75 CA2 (0.46) CA2CA1CA9MAPK1CA12
SCHEMBL5018093 0.75 EDNRA (0.53) CA2CA1CA9MAPK1CA12
SCHEMBL1990221 0.74 LRRK2 (0.49) CA2CA1CA9LRRK2CA12
SCHEMBL29442129 0.74 LRRK2 (0.49) CA2CA1CA9LRRK2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108884046-A chemical compounds as inhibitors of kinase activity 葛兰素史克知识产权开发有限公司 2018-11-23 CN disclosed
EP-2382215-A1 DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI (FR) 2011-11-02 EP disclosed
WO-2010076525-A1 DERIVATIVES OF 2-PYRIDIN-2-YL-PYRAZOL-3(2H)-ONE, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2010-07-08 WO disclosed